Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
Aurélie Hanoteau(Baylor College of Medicine), Andrew G. Sikora(Baylor College of Medicine), Angelina Gaspero(Baylor College of Medicine), Hsuan‐Chen Liu(Baylor College of Medicine), Robyn D. Gartrell(Johns Hopkins University), Saskia J. Santegoets(Amsterdam UMC Location Vrije Universiteit Amsterdam), Falguni Parikh(Baylor College of Medicine), Sjoerd H. van der Burg(Leiden University Medical Center), Chen Huang(Baylor College of Medicine), Jo A. Van Ginderachter(Vrije Universiteit Brussel), Thomas D. Hart(Penn Presbyterian Medical Center), Damya Laoui(Vrije Universiteit Brussel), Yvonne M. Saenger(Penn Presbyterian Medical Center), Bing Zhang(Baylor Genetics), Cornelis J.M. Melief(ISA Pharmaceuticals (Netherlands)), Jared M. Newton(Baylor College of Medicine), Rosemarie Krupar(University Hospital Schleswig-Holstein), Padmini Jayaraman(Baylor College of Medicine), Chad Spanos(University of South Dakota)
Cited by 89
Related Papers
Therapeutic cancer vaccines
|Journal of Clinical Investigation|2015|1.1k